{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:01:05Z","timestamp":1792022465949,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.critrevonc.2010.04.007","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T08:38:45Z","timestamp":1275381525000},"page":"112-126","source":"Crossref","is-referenced-by-count":136,"title":["Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature"],"prefix":"10.1016","volume":"78","author":[{"given":"K.","family":"Kamposioras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pentheroudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pectasides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.critrevonc.2010.04.007_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.22126","article-title":"The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003","volume":"107","author":"Lasithiotakis","year":"2006","journal-title":"Cancer"},{"issue":"March\u2013April (2)","key":"10.1016\/j.critrevonc.2010.04.007_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib3","first-page":"341","article-title":"Malignant melanoma of unknown primary origin","volume":"117","author":"Das Gupta","year":"1963","journal-title":"Surg Gynecol Obstet"},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2010.04.007_bib4","first-page":"90511","article-title":"End results in the treatment of malignant melanoma; a report of 1190 cases","volume":"136","author":"Pack","year":"1952","journal-title":"Ann Surg."},{"key":"10.1016\/j.critrevonc.2010.04.007_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ijc.1491","article-title":"Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melanA\/MART-1","volume":"94","author":"Saleh","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<602::AID-IMMU602>3.0.CO;2-Y","article-title":"A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion","volume":"29","author":"Zorn","year":"1999","journal-title":"Eur J Immunol"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2010.04.007_bib7","first-page":"400","article-title":"Patient characteristics, treatment, and outcome of unknown primary melanoma in the United States for the years 1981 and 1987","volume":"62","author":"Sutherland","year":"1996","journal-title":"Am Surg"},{"issue":"July (21)","key":"10.1016\/j.critrevonc.2010.04.007_bib8","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1200\/JCO.2008.18.9845","article-title":"Improved survival for stage IV melanoma from an unknown primary site","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2010.04.007_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archotol.125.6.635","article-title":"Malignant melanomas of the parotid: comparison of survival for patients with metastases from known vs unknown primary tumor sites","volume":"125","author":"Wang","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib10","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/sim.1191","article-title":"A comparison of hand searching versus MEDLINE searching to identify reports of randomized controlled trials","volume":"21","author":"Hopewell","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00000658-196406000-00013","article-title":"Malignant melanoma: report of 203 patients","volume":"June (159)","author":"McSwain","year":"1964","journal-title":"Ann Surg"},{"issue":"August (8)","key":"10.1016\/j.critrevonc.2010.04.007_bib12","first-page":"1995","article-title":"Prognostic correlations and response to treatment in advanced metastatic malignant melanoma","volume":"34","author":"Einhorn","year":"1974","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archsurg.1975.01360140040008","article-title":"Malignant melanoma: the patient with an unknown site of primary origin","volume":"110","author":"Baab","year":"1975","journal-title":"Arch Surg"},{"issue":"May (5 Pt 1)","key":"10.1016\/j.critrevonc.2010.04.007_bib14","first-page":"460","article-title":"Melanoma of the head and neck","volume":"87","author":"Conley","year":"1977","journal-title":"Laryngoscope"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/bjs.1800641114","article-title":"Occult primary malignant melanoma: factors influencing survival","volume":"64","author":"Milton","year":"1977","journal-title":"Br J Surg"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00000658-198001000-00018","article-title":"Clinical aspects of unknown primary melanoma","volume":"191","author":"Giuliano","year":"1981","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.2930190308","article-title":"Malignant melanoma with unknown primary site","volume":"19","author":"Lopez","year":"1982","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/1097-0142(19820315)49:6<1106::AID-CNCR2820490607>3.0.CO;2-0","article-title":"Metastatic melanoma of unknown primary","volume":"49","author":"Chang","year":"1982","journal-title":"Cancer"},{"issue":"October (4)","key":"10.1016\/j.critrevonc.2010.04.007_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9610(83)90227-1","article-title":"Cervical node metastasis of occult origin","volume":"146","author":"Spiro","year":"1983","journal-title":"Am J Surg"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2010.04.007_bib20","first-page":"335","article-title":"Metastatic malignant melanoma with an unknown primary","volume":"156","author":"Reintgen","year":"1983","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jso.2930230104","article-title":"Metastatic malignant melanoma of unknown primary origin: a study of 30 cases","volume":"23","author":"Panagopoulos","year":"1983","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jso.2930240213","article-title":"Unknown primary melanoma","volume":"24","author":"Klausner","year":"1983","journal-title":"J Surg Oncol"},{"issue":"October (4)","key":"10.1016\/j.critrevonc.2010.04.007_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-9610(85)90165-5","article-title":"Melanoma metastatic to cervical and parotid nodes from an unknown primary site","volume":"150","author":"Santini","year":"1985","journal-title":"Am J Surg"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2010.04.007_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007611-198603000-00007","article-title":"Isolated perfusion of extremities for metastatic melanoma from an unknown primary lesion","volume":"79","author":"Muchmore","year":"1986","journal-title":"South Med J"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archsurg.1987.01400240026003","article-title":"Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site","volume":"122","author":"Wong","year":"1987","journal-title":"Arch Surg"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/bjs.1800770625","article-title":"Lymph node metastasis from melanoma with an unknown primary site","volume":"77","author":"Jonk","year":"1990","journal-title":"Br J Surg"},{"issue":"November (5)","key":"10.1016\/j.critrevonc.2010.04.007_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00000658-199111000-00014","article-title":"Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis","volume":"214","author":"Coit","year":"1991","journal-title":"Ann Surg"},{"issue":"December (12)","key":"10.1016\/j.critrevonc.2010.04.007_bib28","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/1097-0142(19911215)68:12<2579::AID-CNCR2820681209>3.0.CO;2-G","article-title":"Treatment of unknown primary melanoma","volume":"68","author":"Velez","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000637-199201000-00021","article-title":"Metastatic melanoma with an unknown primary","volume":"28","author":"Norman","year":"1992","journal-title":"Ann Plast Surg"},{"issue":"November (10)","key":"10.1016\/j.critrevonc.2010.04.007_bib30","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V","article-title":"Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis","volume":"72","author":"Sirott","year":"1993","journal-title":"Cancer"},{"issue":"April (2)","key":"10.1016\/j.critrevonc.2010.04.007_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2273.1994.tb01203.x","article-title":"Lymph node metastases in the neck and parotid gland from an unknown primary melanoma","volume":"19","author":"Balm","year":"1994","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2010.04.007_bib32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1288\/00005537-199410000-00002","article-title":"Malignant melanoma of cervical and parotid lymph nodes with an unknown primary site","volume":"104","author":"Nasri","year":"1994","journal-title":"Laryngoscope"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2010.04.007_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mpo.2950240509","article-title":"Malignant melanocytic lesions of unknown primary site in children and adolescents","volume":"24","author":"Pappo","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<60::AID-CNCR8>3.0.CO;2-J","article-title":"Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations","volume":"80","author":"Schlagenhauff","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib35","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1816::AID-CNCR26>3.0.CO;2-#","article-title":"Melanoma of unknown primary site","volume":"79","author":"Anbari","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib36","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1008201931959","article-title":"Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study","volume":"9","author":"Vijuk","year":"1998","journal-title":"Ann Oncol"},{"issue":"April\u2013May (3)","key":"10.1016\/j.critrevonc.2010.04.007_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10434-999-0255-5","article-title":"Positive iliac and obturator nodes in melanoma: survival and prognostic factors","volume":"6","author":"Strobbe","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2010.04.007_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00008390-200512000-00008","article-title":"Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour?","volume":"15","author":"de Wilt","year":"2005","journal-title":"Melanoma Res"},{"issue":"February (1)","key":"10.1016\/j.critrevonc.2010.04.007_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00008390-200502000-00013","article-title":"Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute","volume":"15","author":"Katz","year":"2005","journal-title":"Melanoma Res"},{"issue":"August (2)","key":"10.1016\/j.critrevonc.2010.04.007_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jso.20592","article-title":"Metastatic melanoma in the breast: a report of 27 cases","volume":"94","author":"Ravdel","year":"2006","journal-title":"J Surg Oncol"},{"issue":"May (9)","key":"10.1016\/j.critrevonc.2010.04.007_bib42","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/cncr.21835","article-title":"Metastatic melanoma to lymph nodes in patients with unknown primary sites","volume":"106","author":"Cormier","year":"2006","journal-title":"Cancer"},{"issue":"April (11)","key":"10.1016\/j.critrevonc.2010.04.007_bib43","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1200\/JCO.2006.08.8310","article-title":"Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base","volume":"25","author":"Lange","year":"2007","journal-title":"J Clin Oncol"},{"issue":"February (4)","key":"10.1016\/j.critrevonc.2010.04.007_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.2007.14.0285","article-title":"Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma","volume":"26","author":"Lee","year":"2008","journal-title":"J Clin Oncol"},{"issue":"July (6)","key":"10.1016\/j.critrevonc.2010.04.007_bib45","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/07357900802027073","article-title":"Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma","volume":"26","author":"Bedikian","year":"2008","journal-title":"Cancer Invest"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib46","article-title":"Melanoma of unknown origin: a case series","author":"Kelly","year":"2009","journal-title":"Ir J Med Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2010.04.007_bib47","first-page":"10","article-title":"Melanoma without detectable primary site with metastases to lymph nodes","volume":"16","author":"Nowecki","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2010.04.007_bib48","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R","article-title":"Spontaneous regression of primary malignant melanomas with regional metastases","volume":"18","author":"Smith","year":"1965","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1097-0142(197701)39:1<164::AID-CNCR2820390127>3.0.CO;2-T","article-title":"Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance","volume":"39","author":"Ridolfi","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00000478-198702000-00008","article-title":"Malignant melanoma primary in lymph node: the case of the missing link","volume":"11","author":"Shenoy","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2559.1992.tb00988.x","article-title":"Histological regression in primary cutaneous melanoma: recognition, prevalence and significance","volume":"20","author":"Blessing","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0002-9610(74)90286-4","article-title":"Spontaneous regression of malignant melanoma: pathologic and immunologic study in a ten year survivor","volume":"127","author":"Maurer","year":"1974","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1523-1747.ep12479662","article-title":"Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma","volume":"97","author":"Tefany","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/path.1369","article-title":"Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens","volume":"200","author":"Saleh","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib55","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00262-005-0018-5","article-title":"Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients","volume":"55","author":"Haanen","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib57","first-page":"233","article-title":"Demonstration of antibodies against human malignant melanoma by immunofluorescence","volume":"64","author":"Morton","year":"1968","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib58","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/bmj.3.5670.547","article-title":"Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease","volume":"3","author":"Lewis","year":"1969","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib59","first-page":"189","article-title":"Clinical and immunological significance of human melanoma cytotoxic antibody","volume":"35","author":"Bodurtha","year":"1975","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib60","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ijc.2910160504","article-title":"Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of the disease","volume":"16","author":"Canevari","year":"1975","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib61","first-page":"101","article-title":"Immunologic aspects of unknown primary melanoma","volume":"87","author":"Giuliano","year":"1980","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jamcollsurg.2003.08.012","article-title":"Endogenous immune response to early-and intermediate stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors","volume":"198","author":"Litvak","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02523659","article-title":"Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?","volume":"7","author":"Hsueh","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib64","article-title":"Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum","author":"Plaza","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib65","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/1097-0142(20010415)91:8<1530::AID-CNCR1162>3.0.CO;2-#","article-title":"Systematic review of the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in melanoma patients","volume":"91","author":"Mijnhout","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.04.007_bib66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/ejso.2002.1366","article-title":"The role of molecular staging in malignant melanoma","volume":"29","author":"Prichard","year":"2003","journal-title":"Eur J Surg Oncol"},{"issue":"August (Suppl. 6)","key":"10.1016\/j.critrevonc.2010.04.007_bib67","doi-asserted-by":"crossref","first-page":"vi14","DOI":"10.1093\/annonc\/mdp256","article-title":"Staging of cutaneous melanoma","volume":"20","author":"Mohr","year":"2009","journal-title":"Ann Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T01:05:54Z","timestamp":1711501554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842810000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1040842810000922"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2010.04.007","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}